newsfilter
← Latest News
GlobeNewswire·

VYNE Therapeutics to Host Virtual R&D Day Event on November 9, 2023

Event will highlight VYN201 Phase 1b trial results, VYN202 preclinical data and VYNE's clinical development plans Program to feature KOL presentation covering unmet need and current treatment landscape in vitiligo